The aim of the study is to assess visual function from neonatal age to 36 months of age in infants at risk of visual impairment due to brain lesion or ocular pathology
Eligibility
Sex
ALL
Min age
2 Days
Max age
36 Months
Healthy volunteers
No
Inclusion Criteria:
* Age between 34 weeks of post-menstrual age and 36 months of life in children born before 37 weeks gestational age
* Genetic syndroms
* Hypoxic Hischemic Encephalopathy
* Brain malformation
* Metabolic diseases
* Ocular pathologies
Exclusion Criteria:
* Patients at low risk of developing neurological outcomes
* Refusal of informed consent
Primary outcome measure(s)
Early Visual Functions in Patients at Risk of Developing Cerebral Visual Impairment. A Pilot Study — 5 years The score of the functional visual assessment will be obtained at neonatal age and at 1-3-6-9-12-18-24-36 months of life will be analysed at each age and compared to neurodevelopment findings using different scales according to age.
These results will be related to the MRI total score (obtained by the sum of scores by site: cortex, basal ganglia, white matter and cerebellum, normal (0), mild abnormal (1), severely abnormal (2)).
Trial sites (1)
Facility
City
Region
Status
Fondazione Policlinico Gemelli
Rome
Italy
Recruiting
More Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.